Article Details

EMA validates Algenex' CrisBio® platform for the manufacturing of vaccines

Retrieved on: 2021-06-22 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

EMA validates Algenex' CrisBio® platform for the manufacturing of vaccines. View article details on hiswai:

Excerpt

Regulator validation supports broad application of insect-based biologics production technology; CrisBio offers significant advantages over existing ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up